[Perioperative treatment of patients with pheochromocytoma combined severe catecholamine cardiomyopathy: 5 cases report].
OBJECTIVE
To discuss perioperative treatment and cardiac function changes after medicine and surgical treatment of pheochromocytoma patients with severe catecholamine cardiomyopathy.


METHODS
Five pheochromocytoma patients with severe catecholamine cardiomyopathy in our hospital for the past 5 years were studied, their general characteristics, clinical manifestations, diagnosis tests summarized and the cardiac function changes before and after the treatment evaluated.


RESULTS
All the 5 patients were diagnosed definitely before operation. After medication, left ventricular ejection fraction (LVEF) of the 5 patients improved and 4 patients' LVEF increased 7-10 days after operation compared with after medication, and one patient's LVEF improved after 3 months.


CONCLUSIONS
Pheochromocytoma patients with severe catecholamine cardiomyopathy should have adequate medication, and their abnormal cardiac function would be reversed after surgical treatment.
Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100032, China.
Peng-hu
PH
Lian
Li
L
Ding
Xue-bin
XB
Zhang
Yu-shi
YS
Zhang
Zhi-gang
ZG
Ji
Han-zhong
HZ
Li
D000310:Adrenal Gland Neoplasms / Q000601:surgery*; D009202:Cardiomyopathies / Q000188:drug therapy*; D002395:Catecholamines; D006801:Humans; D019990:Perioperative Care; D010673:Pheochromocytoma / Q000601:surgery*; D016277:Ventricular Function, Left
D002395:Catecholamines